Invokana Side Effects

Invokana was marketed as a Janssen’s product and with its easy dietary restrictions compared to the other similar drugs, this became one of the most well-liked medications for diabetes. Unfortunately, soon after it was released for public use, there were plenty of adverse reports submitted to the FDA and the victims claimed for  invokana settlements . In fact, in May 2015, the administration body warned about Invokana's potentially life-altering health effect diabetic ketoacidosis (which is the condition of having excess amount of ketones in the body) and how it is an needless risk associated with the drug. In September 2015, there was a revised FDA warning which highlighted about how the drug can increase the risk of bone fracture and have reduced bone mineral density. The patients taking Invokana are twice more likely to face the risk of leg or foot amputation than those thriving on other similar medication. The other complications associated with the drug are: hypotensi...

Invokana is an SGLT2 inhibitor designed to block a specific protein that helps the body reabsorb glucose in the bloodstream.  Sadly, many patients who are prescribed Invokana to treat their Type-II diabetes have experienced serious complications, often resulting fatal. Many lawsuits have been filed against the manufacturer. Invokana lawsuit update claims that the drug manufacturer didn’t warn the patients and physicians about the possible side effects.  The legal papers plainly insist that if the drug manufacturer had prior and adequate warnings against Invokana and its side effects, the physicians would have informed the patients of the risks, if prescribed at all.  Some of the most prominent cases involving Invokana are: September 2015: An Invokana lawsuit for $1 billion (general and special damages more than $500 million each) was filed on behalf of Canadians in Ontario. Under a request for class-action status, the manufacturers involve a...